Crescentis Capital Limited Rebrands, Shifts to NBFC Model, Eyes Growth

Crescentis Capital Limited's total income turned positive at ₹1.55 crore, and its net loss narrowed to ₹2.53 crore for the financial year ending March 31, 2026.

Reader Takeaway: Strategic pivot to lending business shows positive income trend; equity investment volatility remains a concern.

What just happened

Crescentis Capital Limited, formerly known as Som Datt Finance Corporation Limited, has officially rebranded and transitioned into a Non-Deposit Taking, Base Layer NBFC-ICC. The company has begun lending operations, offering term loans, working capital, and personal loans. For the financial year 2025-26, its total income turned positive at ₹1.55 crore, a significant improvement from a loss of ₹3.02 crore in the previous year. The net loss has been reduced to ₹2.53 crore from ₹5.42 crore.

The company also announced a board approval on May 29, 2026, to raise up to ₹80 crore through a rights issue. This move aims to augment capital for future business expansion.

Why this matters

This strategic pivot marks a significant transformation for Crescentis Capital, moving from its previous identity towards active lending operations. The positive income generation and reduced net loss are key indicators of the nascent lending business gaining traction. The planned ₹80 crore rights issue signals the management's intent to aggressively scale operations and strengthen its capital base, which could unlock future growth opportunities for shareholders.

The backstory

The rebranding from Som Datt Finance Corporation Limited to Crescentis Capital Limited became effective on January 6, 2026. In July 2025, the company successfully raised ₹49.04 crore through a rights issue, which was oversubscribed by 123%. This earlier capital infusion likely supported the initial setup and commencement of its lending operations in June 2025.

What changes now

With the transition to an NBFC model and the commencement of lending, Crescentis Capital is now focused on building its loan portfolio across MSME, renewable energy, and healthcare finance. The company aims to scale its lending activities, supported by the capital from the proposed ₹80 crore rights issue. Investors will now track the growth of the loan book, asset quality, and the effective deployment of new capital.

Risks to watch

Despite the positive developments, investors should note that the company is in the early stages of its lending operations, having commenced in June 2025. The impact of unrealized fair value losses on its equity investment portfolio continues to affect reported net profit/loss, even though these are non-cash items. Gross NPA stood at 0.34% and Net NPA at 0.26% as of March 31, 2026, on a net loan book of ₹45.95 crore, which indicates the need for close monitoring as the portfolio grows.

Peer comparison

As Crescentis Capital operates as an NBFC-ICC, its performance will be benchmarked against other smaller NBFCs focusing on similar lending segments. Key metrics to watch include loan book growth, Net Interest Margins (NIMs), asset quality (NPAs), and return ratios. Detailed peer comparison requires specific financials of comparable NBFCs which are not provided in the filing.

Context metrics (time-bound)

• Gross NPA: 0.34%
• Net NPA: 0.26%
• Net Loan Book: ₹45.95 crore (as of March 31, 2026)
• Total Assets: ₹91.25 crore (as of March 31, 2026)
• Borrowings: ₹14.49 crore (as of March 31, 2026)
• Debt-to-Equity Ratio: 0.19x

What to track next

Investors should monitor the progress of the proposed ₹80 crore rights issue, the growth trajectory of the loan portfolio, and the maintenance of healthy asset quality. Performance of the equity investment portfolio and its impact on reported earnings will also be crucial to observe.